Kalowski Lee 4
4 · Q32 Bio Inc. · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Q32 Bio (QTTB) CFO Kalowski Lee Sells 3,995 Shares
What Happened
- Kalowski Lee, CFO and President of Q32 Bio Inc. (QTTB), disposed of 3,995 shares on 2026-02-25 in transactions reported as sales (S). The weighted-average price was $4.51, for aggregate proceeds of about $18,035. The shares were sold at prices ranging from $4.35 to $4.69 across multiple trades.
Key Details
- Transaction date: 2026-02-25; filing date: 2026-02-27.
- Price: weighted average $4.51; individual trade prices ranged $4.35–$4.69 (reporting person can provide a breakdown on request per footnote).
- Shares after transaction: not specified in the provided filing excerpt.
- Footnotes: F1 — sales were automatic to cover tax withholding on vesting restricted stock units (not at the reporting person's discretion). F2 — weighted-average price; detailed per-price breakdown available on request.
- Timeliness: filing shows a 2‑day lag between transaction and filing (2026-02-25 transaction, filed 2026-02-27); no late-filing notice is indicated in the provided data.
Context
- This sale appears to be a routine, automatic tax-withholding sale tied to the vesting of RSUs rather than a discretionary sell decision. Such transactions are common and generally not taken as a directional signal about insider sentiment.
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
Kalowski Lee
CFO and President
Transactions
- Sale
Common Stock
[F1][F2]2026-02-25$4.51/sh−3,995$18,035→ 35,943 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.35 to $4.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Signature
/s/ Eric Bell, Attorney-in-Fact|2026-02-27